Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Molecular design of near-infrared fluorescent Pdots for tumor targeting: aggregation-induced emission versus anti-aggregation-caused quenching.

Tsai WK, Wang CI, Liao CH, Yao CN, Kuo TJ, Liu MH, Hsu CP, Lin SY, Wu CY, Pyle JR, Chen J, Chan YH.

Chem Sci. 2018 Oct 4;10(1):198-207. doi: 10.1039/c8sc03510e. eCollection 2019 Jan 7.

2.

Kinetic Model under Light-Limited Condition for Photoinitiated Thiol-Ene Coupling Reactions.

Sy Piecco KWE, Aboelenen AM, Pyle JR, Vicente JR, Gautam D, Chen J.

ACS Omega. 2018 Oct 31;3(10):14327-14332. doi: 10.1021/acsomega.8b01725. Epub 2018 Oct 29.

3.

Ultrafast Transient Absorption Spectra of Photoexcited YOYO-1 molecules call for additional investigations of their fluorescence quenching mechanism.

Wang L, Pyle JR, Cimatu KA, Chen J.

J Photochem Photobiol A Chem. 2018 Dec 1;367:411-419. doi: 10.1016/j.jphotochem.2018.09.012. Epub 2018 Sep 10.

PMID:
30410276
4.

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.

Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Craig Jordan V.

Breast Cancer Res. 2018 Jun 14;20(1):57. doi: 10.1186/s13058-018-0986-y.

5.

Correction: Photobleaching of YOYO-1 in super-resolution single DNA fluorescence imaging.

Pyle JR, Chen J.

Beilstein J Nanotechnol. 2018 Mar 6;9:809-811. doi: 10.3762/bjnano.9.74. eCollection 2018.

6.

Photobleaching of YOYO-1 in super-resolution single DNA fluorescence imaging.

Pyle JR, Chen J.

Beilstein J Nanotechnol. 2017 Nov 2;8:2296-2306. doi: 10.3762/bjnano.8.229. eCollection 2017. Erratum in: Beilstein J Nanotechnol. 2018 Mar 6;9:809-811.

7.

Molecular Engineering and Design of Semiconducting Polymer Dots with Narrow-Band, Near-Infrared Emission for in Vivo Biological Imaging.

Ke CS, Fang CC, Yan JY, Tseng PJ, Pyle JR, Chen CP, Lin SY, Chen J, Zhang X, Chan YH.

ACS Nano. 2017 Mar 28;11(3):3166-3177. doi: 10.1021/acsnano.7b00215. Epub 2017 Feb 23.

PMID:
28221751
8.

A Two-Step Method for smFRET Data Analysis.

Chen J, Pyle JR, Sy Piecco KW, Kolomeisky AB, Landes CF.

J Phys Chem B. 2016 Jul 28;120(29):7128-32. doi: 10.1021/acs.jpcb.6b05697. Epub 2016 Jul 14.

PMID:
27379815
9.

Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.

Chang MY, Smith C, DuHadaway JB, Pyle JR, Boulden J, Soler AP, Muller AJ, Laury-Kleintop LD, Prendergast GC.

Cancer Biol Ther. 2011 Dec 15;12(12):1050-8. doi: 10.4161/cbt.12.12.18142. Epub 2011 Dec 15.

10.

Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.

Patel RR, Sengupta S, Kim HR, Klein-Szanto AJ, Pyle JR, Zhu F, Li T, Ross EA, Oseni S, Fargnoli J, Jordan VC.

Eur J Cancer. 2010 Jun;46(9):1537-53. doi: 10.1016/j.ejca.2010.02.018. Epub 2010 Mar 18.

11.

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.

Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.

Breast Cancer Res. 2008;10(6):R104. doi: 10.1186/bcr2208. Epub 2008 Dec 5. Erratum in: Breast Cancer Res. 2018 Jun 14;20(1):57.

12.

Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen.

Ariazi EA, Leitão A, Oprea TI, Chen B, Louis T, Bertucci AM, Sharma CG, Gill SD, Kim HR, Shupp HA, Pyle JR, Madrack A, Donato AL, Cheng D, Paige JR, Jordan VC.

Mol Cancer Ther. 2007 Nov;6(11):2817-27. Epub 2007 Nov 7.

13.

Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.

Ariazi EA, Lewis-Wambi JS, Gill SD, Pyle JR, Ariazi JL, Kim HR, Sharma CG, Cordera F, Shupp HA, Li T, Jordan VC.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):128-38. Epub 2006 Nov 7.

Supplemental Content

Support Center